450 related articles for article (PubMed ID: 28609444)
1. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
2. Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
Han Y; Adeyemi OS; Kabir MHB; Kato K
Parasitol Res; 2020 May; 119(5):1675-1681. PubMed ID: 32236711
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
[TBL] [Abstract][Full Text] [Related]
5. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii.
Tomavo S; Boothroyd JC
Int J Parasitol; 1995 Nov; 25(11):1293-9. PubMed ID: 8635881
[TBL] [Abstract][Full Text] [Related]
6. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
7. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
[TBL] [Abstract][Full Text] [Related]
8. A protein extract and a cysteine protease inhibitor enriched fraction from Jatropha curcas seed cake have in vitro anti-Toxoplasma gondii activity.
Soares AM; Carvalho LP; Melo EJ; Costa HP; Vasconcelos IM; Oliveira JT
Exp Parasitol; 2015 Jun; 153():111-7. PubMed ID: 25816973
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii.
Martins-Duarte ES; Portes JA; da Silva RB; Pires HS; Garden SJ; de Souza W
Bioorg Med Chem; 2021 Nov; 50():116467. PubMed ID: 34666274
[TBL] [Abstract][Full Text] [Related]
10. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Activity of Decoquinate and Its Quinoline-
Ramseier J; Imhof D; Anghel N; Hänggeli K; Beteck RM; Balmer V; Ortega-Mora LM; Sanchez-Sanchez R; Ferre I; Haynes RK; Hemphill A
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770802
[TBL] [Abstract][Full Text] [Related]
12. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.
Montazeri M; Mehrzadi S; Sharif M; Sarvi S; Shahdin S; Daryani A
Parasitol Res; 2018 Oct; 117(10):3045-3057. PubMed ID: 30088074
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
14. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
Saito H; Murata Y; Nonaka M; Kato K
J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
[TBL] [Abstract][Full Text] [Related]
15. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
16. Novel Toxoplasma gondii inhibitor chemotypes.
Sanford AG; Schulze TT; Potluri LP; Hemsley RM; Larson JJ; Judge AK; Zach SJ; Wang X; Charman SA; Vennerstrom JL; Davis PH
Parasitol Int; 2018 Apr; 67(2):107-111. PubMed ID: 29081387
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
Abugri DA; Witola WH; Russell AE; Troy RM
Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro anti-Toxoplasma gondii activity of a new series of aryloxyacetophenone thiosemicarbazones.
Ansari M; Montazeri M; Daryani A; Farshadfar K; Emami S
Mol Divers; 2020 Nov; 24(4):1223-1234. PubMed ID: 31485890
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
20. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
